ROBERT® as an Intervention to Enhance Muscle Strength After Spinal Cord Injury

Feasibility and Effect Size of an Intervention to Enhance Muscle Strength Assisted by Robotic Technology (ROBERT®) in Subacute Rehabilitation After Spinal Cord Injury

Spinal cord injury (SCI) is a devastating life event with long term consequences both physically and mentally. SCI is defined as either complete or incomplete according to the International Standards of the Neurological Classification of SCI. The primary consequence of a SCI is paralysis/partial paralysis affecting the person's ability to independently functioning in everyday life e.g. in and out of bed, sit to stand and walking.

To regain the ability to transfer and walk the most important prerequisite is to rebuild as much strength as possible in the lower extremities. The optimal training paradigm to increase strength in partial paralysed muscles is unclear.

Rehabilitation robots are upcoming methods to treat sensorimotor deficits after SCI.

The rehabilitation robot ROBERT might contribute to enhance muscle strength for people with very weak strength following an incomplete SCI.

The overall objective of this Ph.D project is to investigate the feasibility and effect size of a muscle strength training intervention assisted by ROBERT® for patients with SCI and severe paresis (muscle strength 1-3 in hip flexion).

Study Overview

Status

Active, not recruiting

Detailed Description

SCI is a devastating life event with long term consequences both physically and mentally.

To regain the ability to transfer oneself and to walk, the most important prerequisite is to rebuild as much strength as possible in the lower extremities. The optimal training paradigm to increase strength in partial paralysed muscles is unclear. The question is whether strength is best improved by applying the principles of progressive resistance training or by focusing on high repetitions with limited resistance.

Rehabilitation robots are upcoming methods to treat sensorimotor deficits after SCI. The rationale is that the use of robotics allows adaptable support and the ability to increase therapy intensity and dose while reducing the physical burden on the therapist.

The rehabilitation robot ROBERT enables the SCI patient to conduct active or guided repetitions of specific movements in the lower extremities in the early rehabilitation phase. The hypothesis is that such use will increase muscle strength faster in the recovery process than when conducting usual physiotherapist training for people with incomplete SCI.

The objective of this PhD project is to:

  1. develop and feasibility test the optimal dose, timing and outcome measures and to examine feasibility, compliance and acceptability of an intervention for lower extremities for people with subacute SCI with the rehabilitation robot ROBERT?
  2. conduct a pilot with-in participant randomized controlled trail to estimate the effect size of an intervention to enhance muscle strength assisted by Robotic technology (ROBERT®) in subacute rehabilitation after spinal cord injury
  3. validate accelerometer-based method to identify the supine hip flexion/extension movement and be able to differentiate it from other activity movement based on the perviosely developed algorithm.

Hypothesis:

  • The patients with subacute SCI and muscle strength 1-3 in manuel muscle testing of hip flexion bilateral will be able to conduct the training with Robert.
  • There is a significant increase in muscle strength (hip flexion) in the leg practicing with ROBERT® for 8 weeks compared to the other leg receiving usual training. By using ROBERT® patients with very weak muscle strength are allowed to practise repetitions with the elimination of gravity and adopted resistance and guidance in the range of movement, where they don't have the strength to perform the entire range of movement.

The knowledge gained in this study will inform the design of a future RCT study and enable a power calculation.

- The refinement of the algorithm to monitor activity will be able to differentiate hip flexion from other activities in patients with SCI

Studies:

  1. Feasibility study This study will be conducted prior to the pilot with-in RCT. Consecutively, 4-8 patients admitted to Spinal Cord Injury Centre of Western Denmark (SCICWD) from November 2021 - June 2022 will be recruited. Patients with SCI (< 3 month), age ≥ 18 year and muscle strength 1 - 3 in one of the lower leg muscle groups measured by manual muscle testing will be included. Exclusion criteria: previous cerebral injury or SCI, previous damage to peripheral nervous system in lower extremities, instable fractures in thorax or lower extremities, muscle strength 0, 4 or 5, weight > 150 kg.

    The patients will conduct 4 weeks training with Robert of one leg 3 times a week.

    Muscle strength will be assessed with Handheld dynamometer (HHD) MicroFET2, (Hoggan Scientific) at baseline and after 4 week. Furthermore descriptive data of recruitment capability, resulting sample characteristics, procedures of the intervention, time consumption intervention will be evaluated. Interviews will be performed to get the patient perspective of the intervention and the acceptability.

    The study has been approved by The Danish Scientific Ethics Commission (ref. no. 1-10-72-276-21).

  2. Pilot with-in participant RCT It will take place at Spinal Cord Injury Centre of Western Denmark (SCICWD) from September 2022 - December 2024. 12 consecutively patients admitted to SCICWD will be recruited. To be eligible to participate participants shall have incomplete SCI (<12 months), be age ≥ 18 year and have weakened muscle strength grade 1 - 3 in hip flexion bilateral measured by manual muscle testing due to SCI. Exclusion criteria were: Previous cerebral injury or SCI, previous damage to peripheral nervous system in lower extremities, instable fractures in thorax or lower extremities, muscle strength 0, 4 or 5 in hip flexion, weight > 150 kg.

    The patient's legs will be randomised to either training with ROBERT® or usual training (control). The Control group/leg will recieve usual practice consisting of 3-5 times physiotherapy a week for 8 weeks. A session last 45 minutes. The sessions are individually adapted and can contain exercise therapy, functional training, assistive devices, electrical stimulation, hydrotherapy and tread mill training.

    Intervention group will receive usual practice. As add-on, the intervention leg will receive 3-4 sets of 15-20 repetitions (30 seconds rest between each set) of muscle strength training for hip flexion with ROBERT® three times a week. The ROBERT is attached to the patient's lower leg and thereby eliminating the gravity of the leg. The physiotherapist guides the patient's leg in hip flexion and ROBERT record the movement. ROBERT is set in active or guided mode and will be individually adjusted. When practice starts the patient get visual feedback to the range of movement of the hip flexion plus the amount of repetitions conducted and persisting.

    From the patients' medical records the following will be collected: Age, sex, injury onset, aetiology, neurological level of injury (NLI) and American Spinal Injury Association Impairment Scale (AIS) grade, and Walking Index for SCI (WISCI). At baseline and after completing the 8 weeks intervention (2-5 days after) muscle strength will be assessed with Handheld dynamometer (HHD) (19) MicroFET2, (Hoggan Scientific) as well as electrical activity in hip flexion muscles assessed by surface Electromyography (sEMG) Keypoint, (Alpine Biomed) (20, 21) and spasticity assessed by Modified Ashworth scale (22, 23). The thickness of the rectus femoris muscle and the quadriceps femoris muscle will be assessed by ultrasound Acuson S2000 (Siemens). Number of hip flexions and activity level will be monitored with accelerometer in both legs all day for three days at baseline, at week 4 of the intervention and the week after completing the intervention.

    Parametric analyses of paired data (post-pre). Discrete variables will be examined with non-parametric analysis. Preliminary data from the feasibility study estimate that it will be realistic to enroll 8-12 persons to complete the study in the period from August 2022 till December 2023.

    The study has been approved by The Danish Scientific Ethics Commission (ref. no. 1-10-72-108-22). The study will be conducted in accordance with the Helsinki Declaration of 2008, the General Data Protection Regulation and legislation and the Data Protection Act. The study is registered at the internal list of research projects at the Central Denmark Region (Ref.nr.1-16-02-276-22).

  3. Validation study This study will be conducted from May 2022-December 2022. 10 healthy adults and 10 patients with SCI admitted SCICWD will be recruited. Accelerometer will be placed with non-allergenic tape at the front and the lateral side of the test person's legs. The test persons will perform supine hip flexion/extension with and without ROBERT® as well as sit-to stand, standing, walking, cycling (Motomed) and transfer from wheelchair to bench. These movements will be recorded with accelerometer as well as video. Validation of the algorithm will be established using video recordings as gold standard.

Study Type

Interventional

Enrollment (Actual)

12

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Midtjylland
      • Viborg, Midtjylland, Denmark, 8800
        • Spinal Cord Injury Centre of Western Denmark

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • SCI (< 12 month),
  • Age ≥ 18 year
  • Muscle strength 1 - 3 in hip flexion in both legs measured by manual muscle testing.
  • Sufficient Danish or English to be able to provide informed consent

Exclusion Criteria:

  • Previous cerebral injury or SCI
  • Previous damage to peripheral nervous system in lower extremities
  • Instable fractures in thorax or lower extremities
  • Muscle strength 0, 4 or 5 in hip flexion
  • Weight > 150 kg

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: ROBERT
The intervention group will receive usual practice. As add-on, the intervention leg will receive 3-4 sets of 15-20 repetitions (30 seconds rest between each set) of muscle strength training for hip flexion with ROBERT® three times a week.

Intervention:

Training will be conducted with the robot ROBERT®. 3 times a week for 8 weeks the patient will conduct 60 repetitions of hip flexion of one leg. The patient is lying supine. ROBERT is attached to the patient's lower leg. The physiotherapist guides the patient's leg in hip flexion and ROBERT record the movement. The ROBERT is attached to the patient's lower leg and thereby eliminating the gravity of the leg. The physiotherapist guides the patient's leg in hip flexion and ROBERT record the movement. ROBERT is set in active or guided mode and will be individually adjusted. When practice starts the patient get visual feedback to the range of movement of the hip flexion plus the amount of repetitions conducted and persisting.

No Intervention: Control
Usual practice in the control group consist of 3-5 times physiotherapy a week for 8 weeks. A session last 45 minutes. The sessions are individually adapted and can contain exercise therapy, functional training, assistive devices, electrical stimulation, hydrotherapy and tread mill training.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Muscle strength in Newton
Time Frame: At baseline and at 8 weeks
Change in maximal voluntary contraction (MVC) in isometric muscle strength (N) of hip flexion (8 weeks - baseline)
At baseline and at 8 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Chance in EMG activity
Time Frame: At baseline and at 8 weeks
Change in amplitude and Root Mean Square (8 weeks - baseline) of m. rectus femoris.
At baseline and at 8 weeks
Change in repetitions
Time Frame: At baseline and at 8 weeks
Change in number of repetitions of hip flexions in both legs (8 weeks - baseline) monitored over 3 days
At baseline and at 8 weeks
Difference between legs in numbers of hip flexion
Time Frame: At 4 weeks
Difference between legs in number of repetitions of hip flexions at week 4 (Intervention leg - control leg) monitored over 3 days
At 4 weeks
Change in spasticity
Time Frame: At baseline and at 8 weeks
Change in spasticity in hip flexors at (8 weeks - baseline)
At baseline and at 8 weeks
Change in muscle thickness
Time Frame: At baseline and at 8 weeks
Change in muscle thickness rectus femoris and quadriceps femoris at (8 weeks - baseline)
At baseline and at 8 weeks
Self-rated hip strength
Time Frame: At 8 weeks
Difference between legs in self-rated hip strength at 8 weeks
At 8 weeks
Self-rated ability to use leg in function
Time Frame: At 8 weeks
Difference between legs in self-rated ability to use the leg in function at 8 weeks
At 8 weeks

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Acceptability and suitability of the intervention - patients' perspective
Time Frame: At 8 weeks
Qualitative interviews: What are patients' experiences of the intervention? Interviews will be transcribed and analysed. Emerging themes will be discussed and if possible incorporated in the intervention
At 8 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Principal Investigator: Susanne Lillelund, MSc, PT, Spinal Cord Injury Centre of Western Denmark

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 21, 2022

Primary Completion (Estimated)

May 30, 2024

Study Completion (Estimated)

December 31, 2024

Study Registration Dates

First Submitted

November 12, 2021

First Submitted That Met QC Criteria

September 23, 2022

First Posted (Actual)

September 28, 2022

Study Record Updates

Last Update Posted (Actual)

April 17, 2024

Last Update Submitted That Met QC Criteria

April 16, 2024

Last Verified

April 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Spinal Cord Injuries

Clinical Trials on Robert - intervention to enhance muscle strength

3
Subscribe